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ABSTRACT  
 
Background: Before introducing proteins from new or alternative dietary sources into the market, a 
compressive risk assessment including food allergic sensitization should be carried out in order to ensure 
their safety. We have recently proposed the adverse outcome pathway (AOP) concept to structure the 
current mechanistic understanding of the molecular and cellular pathways evidenced to drive IgE-
mediated food allergies. This AOP framework offers the biological context to collect and structure 
existing in vitro methods and to identify missing assays to evaluate sensitizing potential of food proteins. 
Scope and Approach: In this review, we provide a state-of-the-art overview of available in vitro 
approaches for assessing the sensitizing potential of food proteins, including their strengths and 
limitations. These approaches are structured by their potential to evaluate the molecular initiating and key 
events driving food sensitization.  
Key Findings and Conclusions: The application of the AOP framework offers the opportunity to anchor 
existing testing methods to specific building blocks of the AOP for food sensitization. In general, in vitro 
methods evaluating mechanisms involved in the innate immune response are easier to address than assays 
addressing the adaptive immune response due to the low precursor frequency of allergen-specific T and B 
cells. Novel ex vivo culture strategies may have the potential to become useful tools for investigating the 
sensitizing potential of food proteins. When applied in the context of an integrated testing strategy, the 
described approaches may reduce, if not replace, current animal testing approaches. 
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1. Introduction 11 
Food allergy is one of the most common health disorders in the western world. The occurrence of food 12 
allergy drastically increased in the last decades with a current prevalence that reaches up to 10% of the 13 
population (Sicherer & Sampson, 2018). Food allergies are adverse reactions to an otherwise harmless 14 
food or food component that involves an abnormal response of the body’s immune system to specific 15 
protein(s) in food. The clinical picture of food allergy is pleiomorphic and can range from gastrointestinal 16 
symptoms to severe anaphylaxis (Eigenmann et al., 2008). Most (approximately 90%) of food allergic 17 
reactions are caused by milk, egg, peanuts, tree nuts, fish, soya, wheat and shell fish (Boyce, Assa, Burks, 18 
Jones, & Hugh, 2010). Allergic disease develops in a two-step process comprising sensitization to the 19 
allergenic food and subsequent elicitation of the allergic reaction resulting in symptoms on re-exposure to 20 
the allergen. 21 
The contribution of food proteins to healthy aging is increasingly documented and the role of these 22 
proteins in a healthy diet recognized. However, a growing global population places an increased pressure 23 
on the world’s resources to provide not only more but also different types of food. The development and 24 
introduction of new dietary protein sources has the potential to improve food supply sustainability. This 25 
can be achieved via different ways, e.g. through development of new nutritional/protein sources, 26 
improvement of crops, by providing solutions to technical challenges during manufacturing, as well as by 27 
valorizing unused side products (Remington et al., 2018; Selb et al., 2017). These foods must not pose a 28 
risk to public health, thus a comprehensive risk assessment should be conducted in order to ensure their 29 
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safety. Risk assessment should cover different domains including kinetics, toxicology, nutritional effects 30 
and allergenicity (de Boer & Bast, 2018).  31 
Studying the allergenicity of these foods is quite complex. Firstly, relevant allergenic testing material 32 
needs to be obtained. To this end, several factors (e.g. pH, buffer, fatty substances in matrix etc), should 33 
be taken into consideration to obtain an extract that provides a good picture of the novel food, which have 34 
to be optimized case-by-case (Mazzucchelli et al., 2018). In addition, the purification of proteins might 35 
also be also technically challenging and may result in chemical modifications, which needs to be assessed 36 
prior to testing for allergenicity (Mazzucchelli et al., 2018). Next to the difficulties to obtain relevant 37 
allergenic testing material, it is evident that properties of food matrix components are also relevant and 38 
important in the sensitization process. The allergen is never in initial contact with the immune system in a 39 
purified state; the matrix surrounds, interacts with, and can affect the physiochemical features of the 40 
allergens. Currently, the primary influences of the matrix are thought to be antigen bioavailability and 41 
release, digestibility and interactions with the immune system (McClain, Bowman, Fernández-Rivas, 42 
Ladics, & Van Ree, 2014). However there are no straightforward approaches to address the many 43 
variables represented by the matrix components in food (reviewed by McClain et al., 2014), so additional 44 
knowledge is required which will help to develop tools to incorporate their influence on sensitization into 45 
model systems (van Bilsen et al., 2017). 46 
This manuscript focusses on the current available in vitro tools to study cellular and molecular 47 
mechanisms driving the non-symptomatic sensitization phase of food allergy resulting in the generation 48 
of food protein-specific IgE.  49 
There are a considerable number of in vivo and in vitro data available describing molecular and cellular 50 
events potentially involved in food sensitization. Recently, these events have been organized in a 51 
sequence of related processes that is plausible to result in sensitization and useful to challenge current 52 
hypothesis by applying the concept of adverse outcome pathway (AOP) (van Bilsen et al., 2017). The 53 
proposed AOP framework provides a simplification of a complex biological process by collecting, 54 
organizing and evaluating data that describe the events of an adverse outcome at a biological level of 55 
organization with relevance for risk assessment. The application of the AOP concept allows to identify 56 
the major molecular initiating events (MIE) and key events (KE) underlying food sensitization (Figure 1). 57 
The AOP for food sensitization starts with a MIE involving the allergen uptake over the mucosal barrier 58 
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of the gut intestine. The food protein passage may induce the activation of intestinal epithelial cells 59 
(IECs), representing KE1, followed by the local activation of dendritic cells (DCs) and their migration to 60 
the mesenteric lymph nodes (KE2 and KE3). There, DCs present processed allergen to naive T cells 61 
priming them toward a T helper type 2 (Th2) response (KE4). Thus these events may cause the activation 62 
of B cells (KE5) and the production of specific IgE by plasma cells.  63 
The events included in this AOP are still highly complex at molecular/cellular level, but the challenge is 64 
to integrate MIE and KE to better understand the mechanistic pathways of food sensitization induction. 65 
The AOP for food allergy offers the opportunity to anchor existing methods for the testing and 66 
assessment of sensitizing potential of food proteins. Moreover, it gives insight into which specific assays 67 
are suitable to evaluate the influence of novel food proteins and ingredients in the sensitization process. 68 
It is still a matter of debate whether human, like mice, can be sensitized via other routes than the oral 69 
route such as via the skin or respiratory route. Epidemiological studies in human populations seem to 70 
confirm the skin as a relevant route for food sensitization induction and allergy in humans, however is 71 
mechanistically not sufficiently understood yet (van Bilsen et al., 2017). Evidence for the respiratory 72 
route is even more ambiguous (van Bilsen et al., 2017). Therefore, in vitro testing strategies focusing on 73 
the dermal or respiratory route are not explored in this review. 74 
In this review, we aim to provide the state-of-the-art of existing in vitro approaches for assessing 75 
sensitizing potential of food proteins based on the identified MIE and KE proposed in the AOP for food 76 
sensitization, as described by van Bilsen et al. (van Bilsen et al., 2017). For this propose, we provide cell 77 
assays previously used for the study of food allergens focusing on major read-outs as well as strengths 78 
and limitations of these assays.. 79 
2. Antigen uptake over intestinal mucosal barrier and epithelium activation 80 
2.1. In vitro models to assess tight junction disruption (MIE1)  81 
During the gastrointestinal digestion, intact proteins and peptide fragments reach the intestinal lumen 82 
where they interact with the IECs resulting in antigen uptake over the gut barrier. Digestion products may 83 
be transferred across the intestinal epithelium by paracellular transport driven by disruption of tight 84 
junctions, adherent junctions and desmosomes, representing MIE1. Tight junctions are multiprotein 85 
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complexes composed by transmembrane proteins (occludin, claudin, junctional adhesion molecule A and 86 
tricellulin) that provide the integrity of the actomyosin ring, which controls inter-epithelial permeability.  87 
Typically, epithelial in vitro models employed to study the transport and absorption of food proteins or 88 
peptides along the intestinal epithelium are based on cell lines (including Caco-2, HT-29, T84, and IPEC-89 
J2) grown in a transwell system (Cubells-Baeza et al., 2015). In this regard, Grozdanovic and co-workers 90 
demonstrated that the exposure of T84 cells to actinidin, a kiwifruit cysteine protease, resulted in the 91 
impairment of the epithelial barrier, due to the degradation of occludin promoted by the proteolytic action 92 
of actinidin (Grozdanovic et al., 2016). As a consequence, an increase of the intestinal permeability was 93 
recorded which could contribute to the process of sensitization in kiwifruit allergy. By employing the 94 
Caco-2 cell model, Price et al showed that peanut allergens Ara h 1 and Ara h 2 were able to alter the 95 
intestinal barrier permeability, modifying the co-localization of the transmembrane tight junction proteins 96 
occludin, JAM-A and claudin-1, with the intracellular adhesion protein ZO-1 (Price, Ackland, Burks, 97 
Knight, & Suphioglu, 2014). In another study, β-conglycinin from soy (Gly m 5) induced a 98 
downregulation of tight junction proteins by using a model of IPEC-J2 porcine cells (Zhao et al., 2015). 99 
On the other hand, the breach of epithelial barrier may be a consequence of Th2 switching and may 100 
possibly reflect the abnormal responses and vicious cycle triggered by mast cell activation. It has been 101 
observed that mast cells releasing chymases and histamine have an impact on the physiology of the 102 
intestinal mucosa, promoting the degradation of the tight junction occludins (Bischoff & Kramer, 2007). 103 
Moreover, mast cells are involved in the release of Th2-realted cytokines, such as IL-4 and IL-13, that 104 
influence the modulation of IEC permeability in different human IEC cultures, decreasing the trans-105 
epithelial electrical resistance (TEER) and selectively increasing the apical-to-basal movement of proteins 106 
(Ceponis, Botelho, Richards, & McKay, 2000). In order to address the integrity of the intestinal 107 
monolayer, the study of the TEER is an important issue that provides information about the inter-108 
epithelial transport, generally associated with an alteration of the tight junctions and thus relates to 109 
paracellular transport. It has been reported that exposure of crude apple homogenate produces an increase 110 
of the paracellular resistance in Caco-2 cells, with an augmentation of the expression of several tight 111 
junction related genes, including claudin 4 (Vreeburg, Bastiaan-Net, & Mes, 2011). Zhao et al. have 112 
recently shown that peptides produced during simulated in vitro digestion of soybean β-conglycinin, 113 
determine an increase of alkaline phosphatase activity with a decrease of mitochondrial respiration (MTT 114 
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assay), TEER values and downregulation of claudin-3, claudin-4, occludin, and ZO-1 expression (Zhao, 115 
Liu, Zhang, Pan, & Qin, 2017). 116 
However, not all food allergens affect TEER resistance. Moreno et al. reported that the transcellular 117 
transport of purified 2s albumins Ber e 1 (brazil nut) and Ses i 1 (sesame seed) across Caco-2 monolayer 118 
did not affect the permeability as assessed by the absence of any change of allergen absorption rate and 119 
TEER values (Moreno, Rubio, Olano, & Clemente, 2006). In other work, authors found that hydrolyzed 120 
ovalbumin did not affect MTT values or cell permeability indicating a protective effect exerted by the 121 
food matrix on the cell barrier (Grootaert et al., 2017). In addition, TEER values were restored to their 122 
original levels, demonstrating the absence of any permanent damage on the monolayer caused by egg 123 
digests tested (Grootaert et al., 2017). In line with this, previous studies also reported that purified 124 
proteins from wheat (ω5-gliadin and LTP 1) (Bodinier et al., 2007), peach (Pru p 3 and LTP 1) 125 
(Tordesillas et al., 2013), and peanut (Ara h 1 and Ara h 2) (Price, Ackland, & Suphioglu, 2017) were 126 
able to cross Caco-2 monolayers without compromising cell monolayer integrity. 127 
2.2. In vitro models to assess receptor-mediated and unspecific endocytosis (MIE2 and MIE3)  128 
Apart from paracellular transport, food proteins may also cross the intestinal epithelium via transcellular 129 
transport pathways, either receptor-mediated (e.g. CD23, the low affinity FcεRII-IgE receptor) (MIE2) or 130 
via unspecific endocytosis (MIE3).  131 
CD23 is expressed by Caco-2, T84 and HT29 cells and their expression can be stimulated by IL-4 (Tu et 132 
al., 2005). Using Caco-2 cells, it has been demonstrated that IgE-antigen (nitrophenyl(NP)-BSA) 133 
complexes trigger the upregulation of IL-8 and CCL20. The supernatant of such triggered Caco-2 cells 134 
induced DC migration in a CCL20-dependent manner (Li et al., 2007). In HT29 cells, it has been shown 135 
that CD23 expression and transcellular transport of IgE-NP-ovalbumin complexes could be stimulated by 136 
factors present in supernatant of activated mast cell (HMC1) and monocyte (THP1) lines (Tu, Oluwole, 137 
Struiksma, Perdue, & Yang, 2009). The role of SIgA in transcytosis has been studied even less than that 138 
of CD23, and mainly focus on gliadin peptides. Caco-2 and HT29 cells express CD71 and 139 
transglutaminase 2 (TG2), both shown to co-precipitate with SIgA and important for endosomal transport 140 
routing (Lebreton et al., 2012). These reports on receptor-mediated endocytosis are from a few isolated 141 
studies, but they show that the role of CD23-mediated and of CD71/TG2 transcytosis could be examined 142 
using in vitro models, although more food proteins using these assays should be tested. 143 
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Unspecific transport of food proteins may occur via epithelial, goblet or M cells and may result not only 144 
in protein degradation within these cells and cellular activation, but also it can lead to process of proteins 145 
into peptides that can be expressed in the context of MHC-II. The route of uptake seems to have an 146 
important implication for the final outcome. Although insufficiently studied, it has been proposed that 147 
larger cross-linked proteins could be more sensitizing because they are preferentially taken up by M cells 148 
and directly interact with immune cells in Peyer’s patches. Roth-Walter and co-workers described that the 149 
intestinal transport of soluble ꞵ-lactoglobulin occurs through enterocytes, while the uptake of its 150 
aggregates is redirected to Peyer's patches (Roth-Walter et al., 2008). On the other hand, smaller intact 151 
proteins are transferred via goblet-associated passage (also called GAP) and that may be linked to 152 
processing by CD103+ DCs, facilitating tolerance rather than to other DCs that are linked to sensitization 153 
(McDole et al., 2012). M cell transfer and GAP are not often studied using in vitro methods, but cell lines 154 
as well as organoids can be adapted to study the particular involvement of these transportation routes. For 155 
instance, cell lines and intestinal stem cell-derived organoids can be stimulated to form M cells by 156 
RANKL-RANK pathway activation (Kimura, 2018) and GAP could be studied in specialized cell lines 157 
(HT29-H cells) or in organoids (constitutive presence of goblet cells).  158 
Endocytosis is a complex process that includes caveolea-mediated uptake mechanisms, clathrin-159 
dependent and -independent uptake mechanisms, macro-pinocytosis and phagocytosis. These processes 160 
may operate alongside each other and can be studied by using specific inhibitors (Dutta & Donaldson, 161 
2012). Important to mention here is that many of these inhibitors (e.g. filipin, cytochalasinD and 162 
monodansylcadaverine) also affect viability as well as TEER values (Price et al., 2017). Little information 163 
with regard to the importance of various mechanisms of endocytosis is yet available for food allergens. 164 
But studies with individual proteins show that different mechanisms of endocytosis may be involved for 165 
different proteins; for instance, Ara h 1 may be endocytosed via a combination of macro-pinocytosis and 166 
clathrin-dependent processes, whereas Ara h 2 may be endocytosed via a combination of macro-167 
pinocytosis and caveolea-mediated uptake mechanisms (Price et al., 2017). Although authors speculate 168 
that the localization of Ara h 2 resulting from the specific way of endocytosis is linked to higher 169 
allergenicity of Ara h 2, other potential explanations such as their different molecular weight or physico-170 
chemical properties should be also considered.  171 
Altogether, in vitro models such as Caco-2 cells cultured onto transwell systems seem suitable to study 172 
the importance of MIE2 and MIE3 in sensitization to food proteins. However, no data is currently 173 
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available for ranges of allergens and clearly this information is needed to link endocytosis per se as well 174 
as the type of translocation to the sensitizing potential of a food protein. 175 
2.3. In vitro models to assess epithelium activation (KE1)  176 
Beyond being transported across the gut epithelial barrier, food proteins and their digestion products are 177 
able to interact with IECs in the intestinal lumen thereby triggering immune responses. It is widely 178 
accepted that food sensitization involves factors from gut epithelium, which are released after the 179 
activation of IECs (KE1). The presence of food allergens in the gut is mainly detected by pattern 180 
recognition receptors (PRRs), such as toll like receptors (TLRs), glycan binding receptors (galectins) or 181 
protease-activated receptors (PARs). This leads to the activation of inflammatory mechanism resulting in 182 
the activation of the NF-κB route and initiate the repair process for the damaged barrier with the 183 
production and secretion of chemokines, cytokines, reactive oxygen species (ROS), and lipid metabolites. 184 
In vitro studies have closely linked the production of ROS to the activation of epithelial cells in the case 185 
of aeroallergens. The presence of IL-13 in the environment and the activation of PAR-2 receptor have 186 
been implicated in the upregulation of ROS production by epithelial cells (Dickinson et al., 2016; 187 
Nadeem et al., 2015). However, the effect of food allergens on IECs have not been so furtherly studied 188 
and we can only report the case of peanut allergens, in which an increase in the nitric oxide synthase gene 189 
expression has been observed (Starkl et al., 2011). 190 
In response to their activation, IECs are also able to release epithelial-specific cytokines (e.g. IL-1, IL-18, 191 
IL-25, IL-33, and the thymic stromal lymphopoietin –TSLP-) that are crucial for the initiation of food 192 
protein sensitization. This cytokine environment induces the activation of DCs, type 2 innate lymphoid 193 
cells (ILC2), basophils, eosinophils, and mast cells, skewing the intestinal immune system towards a Th2 194 
response. IL-33, IL-25, and TSLP are constitutively expressed by epithelial cells being IL-33 a crucial 195 
regulator of mast cells. Besides that, IL-33 is able to enhance granulocyte, macrophage, and ILC2 196 
responses (Saluja, Khan, Church, & Maurer, 2015). IL-25 elicits multipotent progenitor type 2 cells, a 197 
population of innate cells promoting type 2 cell immunity even in absence of ILC2 (Saenz et al., 2013). 198 
Regarding TSLP, its expression is increased in a NF-κB dependent-manner, being able to activate mast 199 
cells and influencing antibody production (Miron & Cristea, 2012). On the other hand, the production of 200 
IEC-derived TGF-β promotes DCs involved in tolerogenic signals, which is an important milestone for 201 
the control of allergic sensitization (Wang & Sampson, 2009). Tordesillas et al. examined the effect of the 202 
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major peach allergen Pru p 3, in comparison with that of the hypoallergenic peach LTP 1 using Caco-2 203 
cells grown in a transwell system. Authors showed that in the presence of Pru p 3 an increased expression 204 
of Th2-driving cytokines (IL-25, IL-33, and TSLP) was observed. However, with the hypoallergenic 205 
protein LTP 1, the induction these cytokines was significantly lower (Tordesillas et al., 2013). In other 206 
study, the effect of the peanut allergen Ara h 2 on IECs showed upregulation of the inflammatory 207 
cytokines IL-1β and IL-8 (Starkl et al., 2011). 208 
Concluding, the activation of epithelial cells is a heterogeneous process in which the cytokine 209 
environment is crucial, for this reason the effects of more food allergens on IECS should be described 210 
using other cell types than Caco-2 cells. Despite the fact that the majority of studies are focused on the 211 
analysis of the cytokines expression, other pathways should be explored, such as mucus secretion or Ca2+-212 
signaling pathway alterations. 213 
2.4. In vitro models to assess antigen uptake combined with epithelium activation (MIE and KE1) 214 
Approaches which combine the possibility to evaluate the contribution of allergens transport (MIE) to 215 
IEC activation and cytokine production (KE1) are important tools for studying the immunogenic 216 
properties of food proteins. The interaction of food allergens with the intestinal epithelium not only leads 217 
to the secretion of innate cytokines, but also the production of chemokines and other soluble factors such 218 
as alarmins (e.g. uric acid, ATP, HMGB1, and S100 proteins) that drive immune polarization by affecting 219 
DC function and the adaptive response (Gavrovic-Jankulovic & Willemsen, 2015; van Bilsen et al., 220 
2017). Furthermore, there is evidence that mediators released by peripheral blood mononuclear cells 221 
(PBMCs) and mast cells contribute to increase intestinal permeability which means that immunologic 222 
status can, by itself, affect IEC activation and the access of the allergen through epithelium (Tordesillas et 223 
al., 2013). 224 
In this sense, several strategies have already been attempted with relative success. IEC lines grown in 225 
transwell systems (e.g. Caco-2, T84, or HCT-8) have been used to assess allergen uptake and subsequent 226 
epithelium activation by measuring cytokine production or changes in gene expression induced by 227 
allergens (Starkl et al., 2011; Tordesillas et al., 2013). In order to study the influence of intestinal soluble 228 
factors from immune cells on IECs, some in vitro strategies have used separate monocultures of IECs and 229 
immune cells and then supernatant from immune cells has been applied to IECs (Martos, Lopez-Exposito, 230 
Bencharitiwong, Berin, & Nowak-Wegrzyn, 2011; Tordesillas et al., 2013; Yamashita, Yokoyama, 231 
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Hashimoto, & Mizuno, 2016) or vice versa. This strategy may contribute to a better comprehensive 232 
understanding of the in vivo cross-talk affecting KE1. 233 
In addition, co-culture systems allowing cross-talk between structural cells (IECs) and effector immune 234 
cells (such as basophils) are being attempted to study whether a food allergen induces not only a direct 235 
epithelial activation, but also its consequences on the underlying immune cells, enabling to assess the 236 
immune cell responses through epithelial activation. An in vitro model based on the co-culture of Caco-2 237 
cells and rat basophilic leukaemia cells (RBLs) has been used for the study of immune activation upon 238 
Gal d 2 challenge at the apical side of the IECs (Thierry, Bernasconi, Mercenier, & Corthesy, 2009). 239 
Although not performed, epithelial activation markers may be evaluated using this co-culture system. 240 
More complex co-cultures combining mucoid IECs, non-mucoid IECs and B cell lines (Caco-241 
2/HT29/Raji-B) have been suggested in the literature as systems to integrate allergen uptake with 242 
epithelial activation markers as well as with modulation by the immune cell signals (Araujo & Sarmento, 243 
2013). However, such an integrative system has not yet been used for the study of food allergens. 244 
3. Dendritic cells 245 
3.1. In vitro models to assess dendritic cell activation and migration (KE2 and KE3) 246 
As major antigen presenting cells, gut-associated DCs play a key role in immunological pathways 247 
associated to food protein sensitization process. Food proteins or their digestion products may induce 248 
activation of DCs (KE2) by C-type lectin receptor (CLRs) or other PRRs leading to a decrease in TLR-249 
induced IL-12 production, as well as upregulation of OX40L, TIM-4, or both. In addition, DCs can be 250 
activated by IEC-derived IL-33 which also upregulates OX40L expression on DCs. After allergen uptake 251 
and activation, DCs migrate (KE3) to draining lymph nodes mediated by the expression of CCR2, CCR5 252 
and CCR7 molecules. Other interesting surface markers to assess as indicators of antigen presentation are 253 
HLA-DR (MHC class II), CD86 (Katayama et al., 2013) and DC-SIGN binding by fluorescent-labeled 254 
food proteins (Kamalakannan, Chang, Grishina, Sampson, & Masilamani, 2016). 255 
Besides DC assays analyzing the presence of (binding to) surface molecules and cytokine expression, 256 
other methods have been described evaluating the differences in DC endocytosis by incubating murine 257 
bone marrow-derived DCs (BM-DCs) with FITC-labeled β-lactoglobulin and by in vitro endolysosomal 258 
degradation of the native and cross-linked forms of this allergen (Stojadinovic, Pieters, Smit, & 259 
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Velickovic, 2014). These data indicated differences that correlated with the sensitizing potential in vivo, 260 
suggesting that these additional parameters may be useful in vitro parameters to evaluate the sensitizing 261 
potential of food proteins. On this regard, BM-DCs have been applied to estimate the effect of thermal 262 
process on ovalbumin and showed that a glycation product of this allergen, pyrraline, induced higher 263 
uptake by DCs associated with the scavenger receptor class A (Heilmann et al., 2014). 264 
Transcriptomic profiling of allergen-activated DCs is another approach to compare the DCs activating 265 
potency of food proteins. Comparison of various cell lines with human monocyte-derived DCs (moDCs) 266 
by gene profiling suggested that the MUTZ-3 cell line resembles moDCs (Larsson, Lindstedt, & 267 
Borrebaeck, 2006). A clone of this cell line has been recently used to assess and predict the sensitizing 268 
potential of proteins in respiratory allergy in the Genomic Allergen Rapid Detection (GARD) assay. In 269 
this assay, cellular responses induced by eight selected proteins were assessed using transcriptional 270 
profiling, flow cytometry and multiplex cytokine analysis. A total of 391 potential biomarkers were 271 
identified as a predictive signature and series of cross-validations supported the effectiveness of this 272 
model. These results together with biological pathway analysis of the transcriptomic data indicate that the 273 
investigated cell system is able to capture relevant events linked to type I hypersensitization (Zeller et al., 274 
2018). Although promising, the relevance of this model for food sensitization induction in general 275 
remains to be established. 276 
Migration assays using BM-DCs (Rhee, Zhong, Reizis, Cheong, & Veillette, 2014) or MUTZ-3 cells 277 
(Rees et al., 2011) have been described in transwell systems in which activated DCs are applied in the 278 
upper chamber, whereas an appropriate chemokine is added to the lower chamber. After incubation, 279 
migrated cells are harvested from the lower chamber and quantified (Rhee et al., 2014). However, these 280 
migration assays have never been proven useful in a food allergen specific context. 281 
3.2. In vitro models to assess interactions between epithelial and dendritic cells (approaches 282 
integrating KE1, KE2 and KE3) 283 
The IECs- and DCs-derived signals constitute an allergen-induced inflammatory microenvironment that 284 
triggers DCs maturation and migration. Test methods incorporating IECs and DCs have been developed 285 
in a variety of formats: co-cultures of DCs/IECs, three-dimensional (3D) models reconciling the complex 286 
and dynamic interactions that exist in vivo between the intestinal epithelium and the luminal side, and 287 
between the epithelium and the underlying immune system on the basolateral side (Bermudez-Brito, 288 
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Plaza-Diaz, Fontana, Munoz-Quezada, & Gil, 2013). These methods have been applied to investigate 289 
cellular and molecular mechanisms triggered by prebiotics and bacteria. However, the impact of allergens 290 
on these mechanisms has not yet been investigated extensively with these test models. Cultures of DCs 291 
supplemented with IEC-conditioned medium may also be considered as alternatives to co-cultures. This 292 
method has been applied in the case of prebiotics using human moDCs cultured with HT-29 conditioned 293 
medium (de Kivit et al., 2017). 294 
Although several studies have used cultures of IECs or DCs to assess the sensitizing potential of food 295 
allergens, only the previously mentioned study from Tordesillas et al. investigated the influence of a food 296 
allergen on the function of co-cultured IECs/DCs. In that study, a transwell system with Caco-2 cells was 297 
set up, including PBMCs from healthy donors in the basolateral compartment. The addition of the Pru p 3 298 
onto the apical chamber induced increased expression of IL-1β, IL-6, IL-10 and TNF-α genes in PBMCs 299 
which was related to the high transport rate of intact Pru p 3 over the Caco-2 barrier (Tordesillas et al., 300 
2013). These types of methods allow a further characterization of the sensitizing potential of allergens by 301 
including the role of cell-cell contact as well as soluble molecules taking into account the cellular 302 
interactions. However, several specific limitations may be encountered during the development of these 303 
methods, such as compatibility of cell types or cell media, complexity of the systems, donor variability 304 
when using primary human cells. 305 
4. T and B cell differentiation 306 
4.1. In vitro models to assess murine Th2 cell priming (KE4) 307 
Allergens are thought to invoke an allergic response due to their ability to activate T cells through their 308 
specific cell receptors (TCRs). Besides this primary pathway, the interaction of co-stimulatory and co-309 
inhibitory receptors of T cells (CD28, CTLA-4, OX40L) with ligands on antigen presenting cells 310 
activates antigen unspecific signals that lead to the differentiation of T cells into a Th2 phenotype (van 311 
Bilsen et al., 2017). 312 
Due to the low allergen-specific T cell in vivo frequency, re-stimulation of pre-sensitized cells ex vivo is 313 
the most widely used method to evaluate priming potential of common food allergens in mice. Most 314 
studies use splenocytes, mesenteric lymph node cells, or a combination of both, although lamina propria 315 
mononuclear cells (Sun et al., 2016) and isolated CD4+ T cells (Kanjarawi et al., 2011; Pochard et al., 316 
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2010) have also been evaluated. Cell suspensions are prepared from immunized mice and cultured with 317 
the antigen for 3-6 days, depending on the subsequent analyses. T cell proliferation, expression of specific 318 
cellular surface markers and/or cytokine secretion are mostly determined in these studies. T cell 319 
proliferation is one of the most common ways to assess T cell activation upon ex vivo re-stimulation with 320 
the allergen. To this end, several methods such as labeling of cells with a fluorescent dye (Pochard et al., 321 
2010; Sun et al., 2016), incorporate a radioactive nucleoside into new strands of chromosomal DNA 322 
during mitotic cell division (Freidl et al., 2017; Stojadinovic et al., 2014) or colorimetric assays for 323 
assessing cell metabolic activity (Sun, Liu, Wang, Liu, & Feng, 2013; Wai, Leung, Leung, & Chu, 2016) 324 
have been used.  325 
Proliferation assays have been performed for ꞵ-lactoglobulin (Mizumachi, Tsuji, & Kurisaki, 2008; 326 
Stojadinovic et al., 2014), ovalbumin (Castro et al., 2012; Sun et al., 2016), tropomyosin (Capobianco et 327 
al., 2008; Wai et al., 2016), Cyp c 1 from carp (Freidl et al., 2017), peanut (Pochard et al., 2010), cashew 328 
and walnut extract (Kulis, Pons, & Burks, 2009), and soybean proteins (Sun et al., 2013), showing in all 329 
the cases a strong proliferative response of the cells. Expression of specific surface markers have been 330 
measured in sensitized mice after challenge with whey and ovalbumin, showing an increase in the 331 
percentage of both, activated Th1 and Th2 cells compare to control animals (Lozano-Ojalvo, Perez-332 
Rodriguez, Pablos-Tanarro, Molina, & Lopez-Fandino, 2017; Vonk et al., 2017). However, when peanut 333 
extract was used there was no difference in the percentage of activated Th2 cells, and the percentage of 334 
activated Th1 cells was decreased (Vonk et al., 2017). 335 
Levels of secreted cytokines are often evaluated by ELISA or flow cytometry in cell culture supernatants. 336 
This method has been used to evaluate several food allergens from cow’s milk (Kanjarawi et al., 2011; 337 
Stojadinovic et al., 2014), peanut (Smit et al., 2015; Zhu et al., 2016), hen’s egg (Pablos-Tanarro, Lopez-338 
Exposito, Lozano-Ojalvo, Lopez-Fandino, & Molina, 2016; Sun et al., 2016), soybeans (Sun et al., 2013) 339 
and shrimp (Wai et al., 2016). Moreover, extracts from whey, hen’s egg white, peanut, cashew, walnut  340 
and sesame seeds have also been evaluated using this method (Lozano-Ojalvo et al., 2017; Smit et al., 341 
2015; Vonk et al., 2017). A high increased secretion of Th2 cytokines (IL-4, IL-5, IL-13) has been 342 
observed in all the studies, whereas some discrepancies were observed between allergenic proteins in 343 
their potency to induce IFN-γ (Stojadinovic et al., 2014; Vonk et al., 2017) and IL-10 (Vonk et al., 2017). 344 
A few studies have measured increased levels of IL-17 (Lozano-Ojalvo et al., 2017; Rupa, Nakamura, 345 
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Katayama, & Mine, 2014) , while in other limited number of studies IL-22 and TNF-α levels showed no 346 
differences compared to non-sensitized control cells (Pablos-Tanarro et al., 2016; Zhu et al., 2016). 347 
The assays described above, have provided efficacy to identify known allergens that drive allergic 348 
reactions in individuals and allergen modifications that ameliorate their allergenic potential, as well as to 349 
identify T cell epitopes of cross-reactivity with other allergens. However, they are not effective to identify 350 
the allergenic potential of new proteins that are responsible for stimulating the underlying Th2 responses, 351 
mainly due to the need to use cells from previously sensitized mice against the same allergen to perform 352 
the assay. Moreover, although evaluation of T cell activation through T cell proliferation assays is widely 353 
describe in the literature using different strategies, the use of indirect methods such as those that measure 354 
mitochondrial activity (e.g. MTT or WST assays) should be avoided because they reflect viable cell 355 
metabolism and not specifically cell proliferation, requiring additional confirmations. 356 
4.2. In vitro models to assess human Th2 cell priming (KE4) 357 
The activation and priming of naive T cells (KE4) for allergic food proteins in the draining lymph nodes 358 
results from the recognition of an epitope presented by Th2 driving DCs in the context of HLA (MHC-II). 359 
Most of the approaches for investigating KE4 using human samples are based on the ex vivo re-360 
stimulation of PBMCs from allergic patients and the study of the allergen-specific induced proliferation 361 
and cytokine production (Flinterman et al., 2010; Tao et al., 2016; Tiemessen et al., 2004; Vocca et al., 362 
2011). Indeed, stimulation of PBMCs from cow’s milk allergic children with β-lactoglobulin was found 363 
to induce cell proliferation and increased IL-13 over IFN-γ release compared to healthy or tolerant 364 
controls (Vocca et al., 2011). Also in PBMCs from peanut allergic patients, allergen-specific proliferation 365 
could be assessed by determining proliferation within the CD25+CD134+CD4+ T cell population after 366 
stimulation with raw peanut (Tao et al., 2016). However, in peanut allergic patients, ex vivo stimulation of 367 
PBMCs with peanut extract increased both IL-13 and IFN-γ as well as TNF-α levels compared to PBMCs 368 
from healthy controls (Flinterman et al., 2010). 369 
However, as pointed out in the previous section for KE4, the precursor frequency of allergen-specific T 370 
cells is very low in the peripheral blood of allergic patients. In this regard, the generation of T cell lines 371 
and T cell clones is an interesting alternative that lead to analyze Th2 cell activation (Flinterman et al., 372 
2010; Tiemessen et al., 2004). Assays to study the functionality of these allergen-specific T cells make 373 
the use of allergen induced selection and cloning to improve the sensitivity of the assay. A mixture of β-374 
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lactoglobulin derived synthetic peptides were used to generate antigen-specific T cell lines and clones 375 
from PBMCs of cow’s milk allergic patients (Sakaguchi et al., 2002). Limiting dilution clones were 376 
isolated and then used for epitope mapping. Results showed a sequence of 12 amino acids recognized by 377 
three out of six T cell clones from 5 different patients, which was associated with presentation via 378 
HLADRB1*0405 (Sakaguchi et al., 2002). Kondo et al. further studied intracellular cytokine expression 379 
in two of those clones, showing an increased production of IL-4 and IFN-γ both in combination with IL-380 
10 (Kondo et al., 2005). In this sense, cytokine release measurement may provide additional information 381 
concerning the type of immune response that is raised against these epitopes. Tiemessen et al. generated T 382 
cell clones using whole cow’s milk proteins and compared the cytokine response in a group of cow’s milk 383 
allergic infants with non-symptomatic allergic patients and healthy donors (Tiemessen et al., 2004). 384 
Results showed that all different groups strikingly reacted to milk proteins, although cytokine production 385 
by allergic individuals was the highest for IL-4, IL-13, IFN-γ, and IL-10 (Tiemessen et al., 2004). 386 
However, only the symptomatic group revealed a negative or no correlation between IL-4/IFN-γ and IL-387 
10, while in the other two groups there was a positive correlation, showing the importance of IL-10 as a 388 
regulatory cytokine involved in tolerance induction. In addition, T cells from the symptomatic group had 389 
a high expression of the activation marker CD69 (Tiemessen et al., 2004). Beyond studying differences in 390 
T cell phenotype between patients and controls, T cell epitope disruption can also be studied using T cell 391 
lines as showed by the fact that β-lactoglobulin was able to induce a higher proliferation and cytokine 392 
secretion than its products of hydrolysis (Knipping et al., 2012). In short-term peanut-specific T cell lines 393 
generated from PBMCs of peanut allergic patients, Ara h 1, Ara h 3, and Ara h 6 were identified to induce 394 
the highest proliferation and secretion of IL-13, showing that these cell lines created using crude peanut 395 
extract can be useful for allergen identification (Flinterman et al., 2010). Furthermore, allergen-specific T 396 
cell clones from HLA diverse donors can be generated in order to evaluate the epitopes involved in T cell 397 
activating capacity in a certain HLA context (Prickett et al., 2011, 2013). This method has been used to 398 
identify 10 core epitopes of Ara h 1 and 5 core epitopes of Ara h 2 that could effectively induce T cell 399 
proliferation in a HLA-DQ and/or HLA-DR and/or HLA-DP restricted manner (Prickett et al., 2011, 400 
2013). In the latter study, it was also showed that Ara h 2 peptides were able to enhance IL-4 and IL-5 401 
secretion (ELISPOT) in PBMCs from peanut allergic donors (Prickett et al., 2011).  402 
Based on an in silico predictions, Ramesh et al. evaluated the immunogenic potential of 36 Ara h 1 403 
derived peptides studying proliferation and cytokine production after ex vivo re-stimulation of PBMCs 404 
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from peanut allergic patients with those peptides (Ramesh et al., 2016). Almost all the in silico selected 405 
peptides induced proliferation and predominantly a high IL-13 release when compared to IFN-γ (Ramesh 406 
et al., 2016). This study indicates that PBMCs from allergic donors, combined with an appropriate in 407 
silico prediction, may yet be sufficient to identify allergenic epitopes of certain food proteins. In addition, 408 
MHC-peptide tetramers assays have been previously used to identify allergen-specific T cells in PBMCs. 409 
DeLong et al. cultured PBMCs from peanut allergic patients with Ara h 1 peptides loaded on biotinylated 410 
HLA-DR proteins and intracellular cytokine expression was identified in tetramer labeled cells (Delong et 411 
al., 2011). Results showed that CCR4 expressing Ara h 1 reactive T cells responded to different epitopes 412 
and produced mostly IL-4 beyond other cytokines (Delong et al., 2011). 413 
In these types of assays, allergen-specific T cells can be identified by a highly upregulated Th2-prone 414 
culturing environment. They may not provide much information regarding the sensitizing potential of a 415 
given food protein, but merely indicate whether specific (or novel) food-derived proteins or peptides can 416 
be recognized by T cells and pose a potential risk. Moreover, these approaches are useful to identity novel 417 
food epitopes that are recognized by T cells. 418 
4.3. In vitro models to assess DC activation/migration and T cell priming (approaches integrating 419 
KE2, KE3 and KE4) 420 
After DC activation (KE2 and KE3), DCs migrate to the draining lymph nodes and drive T cell activation 421 
and differentiation (KE4). In vitro models to study antigen presentation and polarization of Th0 toward 422 
Th2 cells are usually based on co-culture approaches using DCs and primed T cells. 423 
In methods based on murine cells, BM-DCs have been co-cultured with CD4+ T cells from mice 424 
sensitized to peanut (Pochard et al., 2010), whey (Stojadinovic et al., 2014) and a panel of purified food 425 
proteins (Smit, de Zeeuw-Brouwer, van Roest, de Jong, & van Bilsen, 2016). In addition, CD4+ T cells 426 
have also been obtained from TCR transgenic strains such as DO11.10 (Ilchmann et al., 2010) or OT-II 427 
mice (Rhee et al., 2014). These studies have showed that DCs increased the expression of 428 
activation/migration markers (MHC-II, CD80, and CD86) and the release of stimulatory cytokines such 429 
as IL-6 and IL-12 after re-stimulation with the allergen. Furthermore, activated DCs induce a high 430 
proliferation and a marked Th2 profile (enhanced production of IFN-γ, IL-4, IL-13, and IL-5 determined 431 
by ELISA) in primed CD4+ T cells. Similar results were obtained when DCs were directly isolated from 432 
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mesenteric lymph nodes and co-cultured with CD4+ T cells from DO11.10 mice (Blazquez & Berin, 433 
2008). 434 
Among human in vitro models, DCs used for co-culture with T cells have been obtained from 435 
differentiated THP-1 cell line (Katayama et al., 2013) and allergen-pulsed monocyte-derived DCs 436 
(Gomez et al., 2012; Scott-Taylor, Axinia, & Strobel, 2017). Allergens have been shown to activate DCs 437 
revealed by an enhanced expression of CD80, CD83, and CD86 (Gomez et al., 2012), production of 438 
inflammatory cytokines (IL-12p70, IL-1β, TNF-α, and IL-10) and up-regulated expression of MARCH 439 
genes. For the study of the cross-talk with T cells, PBMCs from healthy donors (Tordesillas et al., 2013) 440 
or cashew allergic patients (Archila et al., 2016) have been previously used. In addition, T cell lines 441 
generated from cow’s milk allergic children (Meulenbroek et al., 2014) and CD4+ T cells directly 442 
isolated from patient allergic to peach (Gomez et al., 2012) and other food allergens (Scott-Taylor et al., 443 
2017) have been previously used for co-cultures. Results have shown that, in presence of the food 444 
allergen, DCs induce T cell proliferation (observed by flow cytometry using carboxyfluorescein 445 
succinimidyl ester molecule -CFSE- or CD154 staining) in sensitized individuals compared to healthy 446 
donors. In addition, allergen-pulsed DCs trigger activation of T cells and increase the production of T 447 
cell-like cytokines such as IL-4, IL-13, and IFN-γ. 448 
One of the strengths of human in vitro models is the use of T cells from allergic patients in an autologous 449 
setting, although it coincides with a downside, the limited number of cells that can be used (Lundberg et 450 
al., 2008). In addition, there are variations in the experimental protocols used for pulsed-DCs alone with 451 
the allergen of interest (Gomez et al., 2012; Scott-Taylor et al., 2017) or combined with maturation 452 
factors, such as TNF-α, IL-1β, or LPS (Ashjaei et al., 2015). These differences during maturation can 453 
affect expression of DC co-stimulatory and maturation markers and thus the subsequent proliferation of T 454 
cells and cytokine production, although most of the studies were able to induce an allergen-specific 455 
response. Despite differences between the in vitro models, co-cultures of DCs/T cells provide useful 456 
information about antigen presentation and polarization ability of DCs in presence of primed CD4+ T 457 
cells. 458 
4.4. In vitro models to assess B cell isotype switching (KE5) 459 
The mechanisms controlling the induction of class switch recombination and production of IgE by 460 
switched B cells have been studied extensively. In vitro, the production of IgE by human B cells, 461 
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specifically induced by IL-4 or IL-13 and signalling via CD40 cell surface molecule, can be monitored 462 
at various levels of the ε class switching process, including during the induction of the sterile ε 463 
transcript, which precedes Ig heavy chain locus rearrangement by quantitative reverse transcription PCR 464 
(RT-qPCR) or Northern blot assay, the detection of production of ε excision circles during the Ig heavy 465 
chain locus rearrangement by PCR and the detection of production of IgE by ELISA as nicely reviewed 466 
by Pène et al., 2005. 467 
Even though several in vitro B cell activation protocols are available (Lin & Calame, 2004; Pène et al., 468 
2005), to the best of our knowledge no protocols have been established so far that investigate the 469 
(various levels of) class switching in a food allergen-specific context. 470 
5. Future perspective 471 
5.1. In vitro micro-fluidics systems 472 
Advances in micro-physiological systems are providing researchers alternative means to gain insights into 473 
the molecular interactions of the gastrointestinal tract. These systems combine the benefits of micro-474 
engineering, micro-fluidics, and cell culture in a bid to recreate the environmental conditions prevalent in 475 
the human gut. It becomes now possible to construct in vitro systems that more closely approximate those 476 
conditions present within the gut on scales identical to those encountered in vivo (Kim, Huh, Hamilton, & 477 
Ingber, 2012). These systems based on micro-fluidics offer numerous advantages over traditional cell-478 
culturing techniques, including a 3D culture environment, greater experimental flexibility, the ability to 479 
precisely tune spatiotemporal oxygen and pH gradients, low shear environments, and the ability for high 480 
throughput experimentation. Although currently available micro-fluidics systems provide promising 481 
approaches to study local mechanisms that drive allergic responses, they have not yet been used to study 482 
any of the MIE or KE including in the AOP for food sensitization. Some examples of available micro-483 
fluid devices are described below. 484 
5.1.1. Human gut-on-a-chip device 485 
A micro device “human gut-on-a-chip” has been developed by the Ingber group at Harvard University, 486 
which is composed of two micro-fluidic channels, separated by a porous flexible membrane coated with 487 
extracellular matrix and lined by Caco-2 cells to mimics the complex structure and physiology of living 488 
intestine. The gut micro-environment is established by flowing fluid, which produces low shear stress 489 
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over the micro-channels and exerts cyclic strain that mimics physiological peristaltic motions (Kim et al., 490 
2012). 491 
5.1.2. NutriChip 492 
NutriChip is another integrated micro-fluidic platform developed by Swiss scientists for investigating 493 
potential immunomodulatory function of dairy food and represents a miniaturized artificial human 494 
gastrointestinal tract (Ramadan et al., 2013). NutriChip is a culture of a confluent layer of Caco-2 cells 495 
separated from co-cultured immune cells by a permeable membrane, which allows studying processes 496 
that characterize the passage of nutrients though the intestinal epithelium, including the activation of 497 
immune cells. NutriChip allows application of in vitro digested food on its apical side and a basolateral 498 
culture of a monocyte line (U937 cells) differentiated into macrophages (Ramadan et al., 2013). 499 
5.1.3. Immuno-HuMiX 500 
Human-microbial cross-talk platform (HuMiX) is also a micro-fluid device that enables the study of 501 
molecular interactions at the host-microbe interface (Eain et al., 2017). The features of HuMiX are similar 502 
to those of the other fluidics systems in which also the microbiome component may be introduced. 503 
Moreover, the system can be expanded to analyze the interactions between the immune system and the 504 
intestinal microbiota in the human gut, the so called Immuno-HuMix model. First steps have been 505 
undertaken to integrate human PBMCs in this system (Eain et al., 2017). 506 
5.2. Organotypic ex vivo cultures 507 
One of the major weaknesses of IEC lines is that they are different from the primary cells of the intestinal 508 
epithelium, from which they had originally been isolated. The selection of cells that survive and expand 509 
in vitro often leads to changes in gene expression profile and altered responses. In this respect, primary 510 
isolated cells may therefore be a better model system to represent processes in the intestinal mucosa. 511 
Promising ex vivo approaches are the generation of intestinal organoids and the culturing of ex vivo 512 
intestine samples. 513 
5.2.1. Intestinal organoids 514 
Major advances have been made in establishing culture conditions that support the long-term propagation 515 
and self-organisation of near-physiological tissue. In general, isolated somatic stem cells from various 516 
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organs are cultured in the presence of specific small molecules and growth factors, reflecting essential 517 
niche components of the respective tissue of origin. A 3D scaffold mimicking the basal lamina has further 518 
been shown to support ex vivo expansion of intestinal stem cells ex vivo and tissue formation that 519 
resembles part of the cellular architecture, hierarchy and physiology of the in vivo counterpart (Sato & 520 
Clevers, 2013). The culture of intestinal crypts and their growth and differentiation to organoids may be 521 
an interesting and easy to handle tool to study allergen interaction and associated signal transduction 522 
pathways in a complex intestinal system. 523 
Despite the requirement for more expensive technology than IEC lines, intestinal organoids have been 524 
shown to have multiple applications and with the recent development of efficient gene-editing tools, it is 525 
now possible to generate highly physiological models of human gastrointestinal diseases (Leushacke & 526 
Barker, 2014). However, the study of allergen transport across the epithelial barrier is limited by the 527 
inaccessibility of food proteins to the apical side of IECs (directed to the lumen of the organoids). 528 
5.2.2. Ex vivo models 529 
Another approach to overcome the major drawbacks of the in vitro cell line-based models may be the use 530 
of complete intestinal tissues. In these models, the asymmetrical distribution of proteins and lipids in the 531 
two plasma membrane domains is facing the intestinal lumen. The internal milieu and the presence of 532 
highly organized structures joining adjacent IECs, enable selective processes of absorption, transport, and 533 
secretion to take place across the intestinal mucosa. The main ex vivo intestinal models for intestinal 534 
protein transport studies include the everted sac technique and the Ussing chamber. These approaches 535 
have been largely used to assess protein transport and, using intestinal tissue from sensitized animals, they 536 
may lead to study the effect of sensitization on allergen uptake. However, both techniques have several 537 
limitations including the rapid loss of the tissue viability and tissue damages during isolation, which may 538 
lead to overestimation of protein transport. Furthermore, the presence of the muscle layer in the everted 539 
sac method may lead to underestimation of protein transport. On the other hand, interspecies differences 540 
complicate extrapolation of data to humans. In this respect, pigs share more physiological and 541 
immunological similarities with humans than rodents and the recently developed InTESTineTM method 542 
may be a medium-throughput alternative. InTESTineTM is based on intestinal tissues from pigs that are 543 
incubated on a rocker platform in a high oxygen incubator (Westerhout et al., 2014). 544 
5.3. In silico approaches 545 
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In silico methodologies and tools like databases and comparison software have been shown useful for the 546 
assessment of potential allergenicity of food proteins based on their properties. These in silico methods 547 
use a number of physico-chemical features (mainly amino acid searches) of proteins that can be predicted, 548 
such as B cell epitopes, T cell epitopes and sequence homologies (as reviewed by Hayes, Rougé, Barre, 549 
Herouet-Guicheney, & Roggen, 2015). They can identify whether a novel protein is an existing allergen 550 
and/or has the potential to cross-react with an existing allergen. However, they cannot identify whether a 551 
novel protein will ‘become’ an allergen, so therefore these approaches have limited value to identify truly 552 
novel allergenic proteins (Hayes et al., 2015). The use of future innovative in silico approaches will be 553 
largely influenced by the choice of databases and algorithms that will be developed, standardized, and 554 
most importantly, empirically validated. 555 
6. Conclusion 556 
Although basic science studies have identified a lot of immune pathways behind the allergic response, 557 
sensitization to food proteins is a complex process involving several molecular and cellular events 558 
(Sicherer & Sampson, 2018; Tordesillas, Berin, & Sampson, 2017). The simplification of the biological 559 
process of food allergy sensitization by applying the AOP concept is an effective strategy to identify in 560 
vitro methods that lead to investigate the sensitizing potential of food proteins. Previously, such an 561 
approach focusing on MIE and KE described in reported AOPs for skin and respiratory sensitization have 562 
been used successfully to study the sensitizing potential chemicals in skin and respiratory allergy 563 
(Ezendam, Braakhuis, & Vandebriel, 2016; Sullivan et al., 2017). 564 
In this review, we have clustered, structured, and discussed the existing in vitro models that are suitable to 565 
study the MIE and KE involved in the AOP for food allergy sensitization (van Bilsen et al., 2017). To the 566 
best of our knowledge, this is the first time that the AOP concept is applied to structure all available in 567 
vitro methods to identify the potential sensitizing capacity of food proteins. In order to recapitulate all the 568 
reviewed assays, focusing on different (combinations of) MIE and KE reflecting the different building 569 
blocks of the AOP, Table 1 summarized in vitro methods used to evaluate the three major food allergens: 570 
chicken ovalbumin (Gal d 2), bovine β-lactoglobulin (Bos d 5) and peanut 2S albumin (Ara h 2).  571 
In general, in vitro methods assessing mechanisms involved in the innate immune response are easier to 572 
address than assays assessing the adaptive immune response of food sensitization: the recognition 573 
molecules used by the innate system (here reflected in MIE, KE1, KE2, and KE3), are expressed broadly 574 
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on a large number of cells, which makes it easier to develop in vitro methodologies to study specific 575 
building blocks of the AOP, as seen by the rich set of available tools. However, more in vitro studies of 576 
the transcellular transport based on epithelial receptors (MIE2) or unspecific endocytosis (MIE3) should 577 
be carried out to better understand the effect of this type of intestinal acquisition in the sensitizing 578 
potential of food proteins. 579 
On the other hand, the adaptive immune system (here reflected in KE4 and KE5) is composed of small 580 
numbers of T and B cells with specificity of any individual allergen. Therefore the responding cells must 581 
proliferate after encountering the allergen in order to attain sufficient numbers to mount an effective 582 
response that can be detected. This feature of the adaptive system complicates the development of in vitro 583 
approaches to assess KE4 and KE5. This is also reflected in Table 1 which depicts a limited number of in 584 
vitro approaches to address KE4 and the absence of an available in vitro assay to assess B cell isotype 585 
switching (KE5) in a food-allergen specific context. 586 
It must be noted that the in vitro models discussed in this manuscript have been developed to obtain a 587 
better understanding of the processes involved in food sensitization. Several of the described in vitro 588 
models (summarized in Table 1) seem to be correlated with the sensitizing potential in vivo and some 589 
show great promise to closely approximate in vivo conditions (e.g. in vitro micro-fluidics systems and 590 
organotypic cultures), however as far as we know, none of the described models have been successfully 591 
used to assess the sensitizing potential of a given food protein by comparing high and low/none 592 
sensitizing food proteins in the assay. To this end, it would be an essential step forward to expand the 593 
panel of tested food proteins by including also low/non-allergenic proteins. Most likely, none of the 594 
assays will be able to distinguish high from low/non allergenic potency by itself; however the assays 595 
combined can provide an important set of data which may be helpful to decide which of the assays are 596 
essential to be part of the weight-of-evidence approach to determine the sensitizing potential of food 597 
proteins. Unfortunately, to date it is not known whether the lack of a suitable in vitro model to assess KE5 598 
(B cell isotype switching) will result in a crucial data gap to determine the sensitizing potential or whether 599 
the KE5-model is redundant in the overall assessment.  600 
In vitro models based on cell lines are very useful as research tools to investigate MIE and KE involved in 601 
food allergy sensitization. However, the closer these cell-based systems are to the actual target tissue, the 602 
better conclusions can be drawn. The main problem was that long-term propagation of native, non-603 
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transformed single cells or cell clusters from the intestine was not feasible and it was generally assumed 604 
that it would not be possible to establish long-term cultures of primary adult tissues without the 605 
introduction of genetic transformations promoting cell proliferation and survival. In recent years, 606 
significant progress has been made in this field and robust systems have been identified. A variety of in 607 
vitro micro-fluidics systems and ex vivo culture strategies has been developed to investigate the function 608 
of the intestinal mucosa, which will help to increase the knowledge of food sensitization process. 609 
Concluding, the application of the AOP framework offers the opportunity to anchor existing testing 610 
methods to specific building blocks of the AOP for food sensitization which provides insight which 611 
specific methods are available and which still need to be developed. When applied in the context of an 612 
integrated testing strategy, such an approach may reduce, if not replace, current animal testing 613 
approaches. 614 
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hen’s egg (Gal d 2) and peanut (Ara h 2), organized following the molecular initiation events and key 970 
events described by the adverse outcome pathway for food allergic sensitization. 971 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Table 1. Main in vitro approaches used to characterize major food allergen of bovine milk (Bos d 5), hen’s egg (Gal d 2) and peanut (Ara h 2), organized following the 
molecular initiation events and key events described by the adverse outcome pathway for food allergic sensitization. 
Event Allergen In vitro method Read-outs Main findings Reference 
MIE 1, 2, 3 
& KE1 
Bos d 5 
Caco-2 and M cells Allergen quantification (SDS-PAGE, Western blot and microscopy). Integrity of ZO-1 (microscopy). 
Enhanced transcellular transport of intact Bos d 5 compared with heated Bos 
d 5. (Rytkönen et al., 2006) 
Caco-2 Allergen quantification (ELISA and microscopy). Bos d 5crossed epithelial barrier by endocytosis whereas tryptic peptides followed para- and transcellular transport. 
(Bernasconi, Fritsché, 
& Corthésy, 2006) 
Caco-2 Allergen quantification (ELISA). Enhanced transport of intact Bos d 5 compared with cross-linked Bos d 5. (Stojadinovic et al., 2014) 
T84, Caco-2 and 
HCT-8 Monolayer integrity (TEER). Cytokine production (ELISA). 
Bos d 5 maintained barrier integrity but increased production of IL-8 in 
HCT-8 cells.  
(Yamashita et al., 
2016) 
Gal d 2 
Caco-2 Allergen quantification (ELISA). Tryptophan residue without a free carboxyl group inhibited Gal d 2 transport. 
(Tesaki & Watanabe, 
2002) 
Caco-2 Monolayer integrity (TEER).  Allergen quantification (ELISA and microscopy). Gal d 2 crossed epithelial barrier by endocytosis and transcellular transport. (Thierry et al., 2009) 
Caco-2 Allergen transport (RBL activation test) Enhanced transport of intact Gal d 2 compared with heated Gal d 2. (Martos et al., 2011) 
Caco-2 Monolayer integrity (TEER and Lucifer Yellow).  Allergen quantification (ELISA and Western blot). Gal d 2 showed higher epithelial passage than dephosphorylated Gal d 2.  
(Matsubara et al., 
2013) 
Ara h 2 
HT-29 Monolayer integrity (TEER). Allergen quantification (ELISA).  Integrity of A20 (Western blot and RT-qPCR). 
Ara h 2 crossed epithelial barrier by endocytosis and reduced A20 
expression. 
(Song, Liu, Huang, 
Zheng, & Yang, 2012) 
Caco-2 Allergen quantification (ELISA and microscopy). Gene expression (RT-qPCR). 
Ara h 2 induced inflammatory responses and showed a reduced binding 
ability.  (Starkl et al., 2011) 
Caco-2 Monolayer integrity (TEER).  Allergen quantification (Western blot, microscopy and LC-MS/MS). Ara h 2 induced disruption of tight junctions. (Price et al., 2014) 
KE 2 & 3 
Bos d 5 Mouse BM-DCs Allergen uptake (flow cytometry). Cytokine production (ELISA). Intact Bos d 5 was internalized faster than cross-linked Bos d 5. (Stojadinovic et al., 2014) 
Gal d 2 
THP-1-derived DCs Allergen uptake (flow cytometry). Gene expression (RT-qPCR).  Cytokine production (ELISA). Apple polyphenols suppressed Gal d 2 presentation via MHC-II degradation. (Katayama et al., 2013) 
Mouse BM-DCs  Migration assay (flow cytometry). Cytokine production (ELISA).   PTPN12 regulated DC migration and antigen-induced T cell responses. (Rhee et al., 2014) 
Ara h 2 
Mouse BM-DCs DC maturation (flow cytometry). TLR signals modulated peanut-induce dendritic cells maturation. (Pochard et al., 2010) 
Human Mo-DCs Expression of DC markers (flow cytometry) Peanut extract and agglutinin induced DC activation. (Kamalakannan et al., 2016) 
KE 4 Bos d 5 
Human T cell 
clones  T cell proliferation ([
3H]-thymidine). Cytokine production (ELISA). Bos d 5 induced Th2 cytokine production, but not enhanced proliferation in 
cow´s milk allergic patients. (Schade et al., 2000) 
Human T cell 
clones Cytokine production (ELISA). T cell activation (flow cytometry). T cell activation status was associated with IL-4 and IL-13 production. 
(Tiemessen et al., 
2004) 
Human PBMCs T cell proliferation (CFSE). Cytokine production (flow cytometry). T cell response was associated with high proliferation and Th2 cytokine production. (Tsuge et al., 2006) 
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Human PBMCs T cell activation (flow cytometry). Gene expression (RT-qPCR). Enhanced expression of FoxP3, Nfat-C2, IL-16 and GATA-3 in patients with persisting cow's milk allergy. (Savilahti et al., 2010) 
Human PBMCs T cell proliferation ([3H]-thymidine). Cytokine production (ELISA). Bos d 5 induced T cell proliferation and production of Th2 cytokines. (Vocca et al., 2011) 
Mouse MLN-
isolated T cells Cytokine production (ELISA). Bos d 5 induced Th2 cytokine production, but low IFN-γ levels. (Kanjarawi et al., 2011)
Human T cell 
clones  T cell proliferation ([
3H]-thymidine). Cytokine production (ELISA). Intact whey proteins induced higher T cell proliferation and production of 
cytokines than their hydrolysates. (Knipping et al., 2012) 
Human T cell lines T cell proliferation ([3H]-thymidine). Cytokine production (ELISA). Intact whey proteins induced T cell proliferation and production of IL-13, IL-10 and IFN-γ. 
(Meulenbroek et al., 
2014) 
Gal d 2 
Human PBMCs  T cell proliferation ([3H]-thymidine). Cytokine production (ELISA). Gal d 2 induced T cell proliferation and high levels of IL-5. (Ng, Holt, & Prescott, 2002) 
Mouse LP-isolated 
mononuclear cells T cell proliferation (CFSE). Cytokine production (flow cytometry). Gal d 2 induced T cell proliferation and increased IL-4+ and IFN-γ+ T cells. (Sun et al., 2016) 
Ara h 2 
Human PBMCs and 
T cell lines  T cell proliferation ([
3H]-thymidine). Cytokine production (ELISPOT). Ara h 2 increased production of IL-4 and IL-5. (Prickett et al., 2011) 
Human PBMCs T cell proliferation and cytokine production (flow cytometry). Ara h 2 induced T cell proliferation and production of Th2 cytokines. (Vissers et al., 2011) 
Human PBMCs  T cell proliferation and expression of T cell markers (flow cytometry). Peanut allergens increased proliferation of CD4+CD25+CD134+ T cells. (Tao et al., 2016) 
KE 2, 3 & 4 
Bos d 5 Co-culture: BM-DCs/primed T cells Allergen uptake (flow cytometry). T cell cytokine production (ELISA). Intact and cross-linked Bos d 5 increased production of Th2 cytokines. 
(Stojadinovic et al., 
2014) 
Gal d 2 Co-culture: BM-DCs/CD4+ T cells DC maturation (flow cytometry). T cell cytokine production (ELISA). 
Glycation enhanced Gal d 2 uptake and CD4+ T cell activation compared 
with intact and heated Gal d 2. (Ilchmann et al., 2010) 
Ara h 2 Co-culture: BM-DCs/primed T cells DC maturation (flow cytometry). T cell cytokine production (ELISA). 
Peanut pulsed-DCs induced Th2 response and production of IL-17 and IFN-
γ. 
(Pochard et al., 2010) 
Ara h 2: peanut 2S albumin; BM-DCs: bone marrow-derived dendritic cells; Bos d 5: bovine β-lactoglobulin; CFSE: Carboxyfluorescein succinimidyl ester; DCs: dendritic cells;FoxP3: forkhead box 
P3; Gal d 2: chicken ovalbumin; GATA-3: GATA binding protein 3; KE: key event; LC-MS/MS: liquid chromatography tandem-mass spectrometry; LP: lamina propria; MIE: molecular initiating 
event; MLN: mesenteric lymph nodes; Mo-DCs: monocyte-derived dendritic cells; Nfat-C2: nuclear factor of activated T cells type 2; PBMCs: peripheral blood mononuclear cells; PTPN12: protein 
tyrosine phosphatase, non-receptor type 12; RBL: rat basophilic leukemia cells; RT-qPCR: quantitative reverse transcription PCR; TLR: toll-like receptor; TEER: trans-epithelial electrical resistance. 
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Figure 1. A tentative Adverse Outcome Pathway describing the mechanistic events driving food sensitization induction. Depicted are those events and relationships with 
substantial evidence for a role in food sensitization induction in human. DC: dendritic cell; *Outside the scope of this manuscript. Adapted from van Bilsen et al., 2017. 
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HIGHLIGHTS 
- The AOP for food sensitization helps to implement in vitro testing approaches. 
- Innate immune mechanisms are easier to address than adaptive response.  
- No in vitro protocols have been established for investigating IgE-class switching. 
- Ex vivo strategies are promising to address multiple key events at the same assay. 
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